Registry for CADASIL
Launched by UNIVERSITY OF WISCONSIN, MADISON · Sep 30, 2022
Trial Information
Current as of May 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is creating a registry, or a list, of people who are interested in participating in future research about a condition called CADASIL, which affects the blood vessels in the brain. If you or a family member has CADASIL or is at risk of developing it, you may be eligible to join this registry. To participate, you need to be at least 18 years old. Once you join, your name will be kept on the list until you decide to opt out.
By joining the registry, you can help researchers learn more about CADASIL and how it affects individuals. This is an opportunity to stay informed about future studies that may be beneficial for you or your loved ones. It's important to know that the trial is currently looking for participants, and anyone who meets the age requirement and has a connection to CADASIL can take part.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • have a loved one or a family member with CADASIL, or are at-risk for CADASIL themselves
- Exclusion Criteria:
- • Under 18 years of age
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
Jane Paulsen, PhD
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials